Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01477671|
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : January 11, 2018
This is a descriptive prospective community-based seroprevalence study.
- To determine the prevalence of specific antibodies (immunoglobulin G [IgG]) against dengue in healthy 5 to 10 year-old children in India.
- To determine the dengue virus serotype (DeNV-1,2,3 and /or 4) specific to the antibodies in positive (IgG) samples
- To estimate the prevalence of specific antibodies (IgG) against Japanese encephalitis in healthy 5 to 10 year-old children in India.
|Condition or disease|
|Dengue Dengue Fever Dengue Hemorrhagic Fever|
|Study Type :||Observational|
|Actual Enrollment :||667 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India|
|Study Start Date :||September 2011|
|Actual Primary Completion Date :||September 2012|
|Actual Study Completion Date :||December 2013|
Participants aged between 5 and 10 year-old on day of inclusion.
- Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4 [ Time Frame: Baseline ]
- Prevalence of positive serum samples with JEV specific IgG antibodies [ Time Frame: Baseline ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01477671
|Kalyani, West Bengali, India, 741235|
|Bangalore, India, 560070|
|Hyderabad, India, 500063|
|New Delhi, India, 110002|
|Study Director:||Medical Director||Sanofi Pasteur SA|